Skip to main content
Log in

Quality of life of patients with Fabry disease

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

This paper is the first of its kind to study the impact of Fabry disease (FD) in affected males, and shows that FD is associated with a significant decline in several domains. Using the medical outcomes study (MOS) SF-36 and a FD-specific questionnaire, we compared the observations found among these patients with that obtained for the general US population and other chronic disease states, including Gaucher disease (GD) (another lysosomal storage disorder), end-stage renal disease, stoke and AIDS. Patients with FD have a score profile most similar to patients with AIDS. In comparison with patients with GD, Fabry patients score substantially lower across all domains. Using simple linear regression, potential predictors of health-related quality of life (HRQOL) for Fabry patients were also determined. As in the general population, stroke, cardiac problems and renal disease lead to substantial decrement in HRQOL. In addition, two disease specific symptoms (acroparesthesia and anhidrosis) and pain are also predictors of decreased quality of life. Currently, no specific therapy for FD exists. As enzyme therapy for FD becomes increasingly available, it will be interesting to evaluate the therapy's impact on the quality of life of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brady RO, Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA 2000; 284(21): 2771–2775.

    Google Scholar 

  2. Schiffmann R, Kopp JB, Austin HA III, et al. Enzyme replacement therapy in fabry disease: A randomized controlled trial. JAMA 2001; 285(21): 2743–2749.

    Google Scholar 

  3. Stewart AL, Greenfield S, Hayes RD. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989; 262(7): 907–913.

    Google Scholar 

  4. Masek BJ, Sims KB, Bove CM, Korson MS, Short P, Norman DK. Quality of life assessment in adults with type 1 Gaucher disease. Qual Life Res 1999; 8: 263–268.

    Google Scholar 

  5. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM. Quality-of-life evaluation using short form 36: Comparison of hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2000; 35(2): 293–300.

    Google Scholar 

  6. Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996; 40(1): 8–17.

    Google Scholar 

  7. McEwen S, Mayo N, Wood-Dauphinee S. Inferring quality of life from performance-based assessments. Disabil Rehabil 2000; 22(10): 456–463.

    Google Scholar 

  8. Anderson JP, Kaplan RM, Coons SJ, Schneiderman LJ. Comparison of the quality of well-being scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. J Clin Epidemiol 1998; 51(9): 755–762.

    Google Scholar 

  9. Ware JE Jr. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.

    Google Scholar 

  10. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30(6): 473–483.

    Google Scholar 

  11. Jacoby A, Baker GA, Steen N, Buck D. The SF-36 as a health status measure for epilepsy: A psychometric assessment. Qual Life Res 1999; 8(4): 351–364.

    Google Scholar 

  12. Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: Reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Brit J Rheumatol 1998; 37(4): 425–436.

    Google Scholar 

  13. Cohen J. Statistical Power Analysis for Behavioral Sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates, Inc., 1988.

    Google Scholar 

  14. Bing EG, Hays RD, Jacobson LP, et al. Health-related quality of life among people with HIV disease: Results from the Multicenter AIDS Cohort Study. Qual Life Res 2000; 9(1): 55–63.

    Google Scholar 

  15. Carod-Artal J, Egido JA, Gonzalez JL, Varela De Seijas E. Quality of life among stroke survivors evaluated 1 year after stroke: Experience of a stroke unit. Stroke 2000; 31(12): 2995–3000.

    Google Scholar 

  16. Damiano AM, Pastores GM, Ware JE. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: Results from a retrospective study. Qual Life Res 1998; 7: 373–386.

    Google Scholar 

  17. Hayes RP, Grinzaid KA, Duffey EB, Elsas LJ. The impact of Gaucher disease and its treatment on quality of life. Qual Life Res 1998; 7(6): 521–534.

    Google Scholar 

  18. Kim P, Warren S, Madill H, Hadley M. Quality of life of stroke survivors. Qual Life Res 1999; 8(4): 293–301.

    Google Scholar 

  19. King RB. Quality of life after stroke. Stroke 1996; 27(9): 1467–1472.

    Google Scholar 

  20. Martinez TY, Pereira CA, dos Santos ML, Ciconelli RM, Guimaraes SM, Martinez JA. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest 2000; 117(6): 1627–1632.

    Google Scholar 

  21. Tsakiris D. Morbidity and mortality reduction associated with the use of erythropoietin. Nephron 2000; 85(Suppl 1): 2–8.

    Google Scholar 

  22. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. New Engl J Med 1996; 334(13): 835–840.

    Google Scholar 

  23. Tsasis P. Health-related quality-of-life measurements in HIV/AIDS care. AIDS Patient Care ST 2000; 14(8): 427–438.

    Google Scholar 

  24. Vale L, Donaldson C, Daly C, et al. Evidence-based medicine and health economics: A case study of end stage renal disease. Health Econ 2000; 9(4): 337–351.

    Google Scholar 

  25. Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Med Care 2000; 38(4): 404–410.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K.F. Gold.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gold, K., Pastores, G., Botteman, M. et al. Quality of life of patients with Fabry disease. Qual Life Res 11, 317–327 (2002). https://doi.org/10.1023/A:1015511908710

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015511908710

Navigation